Because he had this early variant, the researchers gave him a combination of the casirivimab and imdevimab monoclonal antibodies from Regeneron.
But it successfully cured the man because he was battling a variant from an earlier phase of the pandemic."The very new variants that are increasing in prevalence now are resistant to all the antibodies available in the UK, the EU and now even the US," Dr Snell said. "Miraculously, he cleared and perhaps this is now the avenue for how we treat these very difficult persistent infections," Dr Snell said, emphasising that this treatment may not translate for normal COVID-19 cases.
Just don’t be in China.
We must take a sample protein and immune cells from him, to prod 💉
Bravo, bravo...
Quote inside Article: “..occurs in a small number of patients with already weakened immune systems” Here’s what potentially damages the immune system:
Maybe a Covid 'false flag', i.e. a 'long rebound'.
At this point he is the mothership
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: thenewpaper - 🏆 7. / 63 Read more »